Evaluation of microstructural brain changes in post-coronavirus disease 2019 (COVID-19) patients with neurological symptoms: a cross-sectional study
Status PubMed-not-MEDLINE Jazyk angličtina Země Čína Médium print-electronic
Typ dokumentu časopisecké články
PubMed
39144056
PubMed Central
PMC11320515
DOI
10.21037/qims-24-162
PII: qims-14-08-5499
Knihovny.cz E-zdroje
- Klíčová slova
- Post-coronavirus disease 2019 neurological symptoms (post-COVID-19 neurological symptoms), corpus callosum (CC), diffusion magnetic resonance tractography (diffusion MR tractography), microstructural brain changes,
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Changes in both the vascular system and brain tissues can occur after a prior episode of coronavirus disease 2019 (COVID-19), detectable through modifications in diffusion parameters using magnetic resonance imaging (MRI) techniques. These changes in diffusion parameters may be particularly prominent in highly organized structures such as the corpus callosum (CC), including its major components, which have not been adequately studied following COVID-19 infection. Therefore, the study aimed to evaluate microstructural changes in whole-brain (WB) diffusion, with a specific focus on the CC. METHODS: A total of 101 probands (age range from 18 to 69 years) participated in this retrospective study, consisting of 55 volunteers and 46 post-COVID-19 patients experiencing neurological symptoms. The participants were recruited from April 2022 to September 2023 at the Institute for Clinical and Experimental Medicine in Prague, Czech Republic. All participants underwent MRI examinations on a 3T MR scanner with a diffusion protocol, complemented by additional MRI techniques. Two volunteers and five patients were excluded from the study due to motion artefacts, severe hypoperfusion or the presence of lesions. Participants were selected by a neurologist based on clinical examination and a serological test for COVID-19 antibodies. They were then divided into three groups: a control group of healthy volunteers (n=28), an asymptomatic group (n=25) with a history of infection but no symptoms, and a symptomatic group (n=41) with a history of COVID-19 and neurological symptoms. Symptomatic patients did not exhibit neurological symptoms before contracting COVID-19. Diffusion data underwent eddy current and susceptibility distortion corrections, and fiber tracking was performed using default parameters in DSI studio. Subsequently, various diffusion metrics, were computed within the reconstructed tracts of the WB and CC. To assess the impact of COVID-19 and its associated symptoms on diffusion indices within the white matter of the WB and CC regions, while considering age, we employed a statistical analysis using a linear mixed-effects model within the R framework. RESULTS: Statistical analysis revealed a significant difference in mean diffusivity (MD) between the symptomatic and control groups in the forceps minor (P=0.001) and CC body (P=0.003). In addition to changes in diffusion, alterations in brain perfusion were observed in two post-COVID-19 patients who experienced a severe course. Furthermore, hyperintense lesions were identified in subcortical and deep white matter areas in the vast majority of symptomatic patients. CONCLUSIONS: The main finding of our study was that post-COVID-19 patients exhibit increased MD in the forceps minor and body of the CC. This finding suggests a potential association between microstructural brain changes in post-COVID-19 patients and reported neurological symptoms, with significant implications for research and clinical applications.
Laboratory Methods Division Institute for Clinical and Experimental Medicine Prague Czech Republic
Laboratory of Immunology Thomayer University Hospital Prague Czech Republic
Zobrazit více v PubMed
Mallah SI, Ghorab OK, Al-Salmi S, Abdellatif OS, Tharmaratnam T, Iskandar MA, Sefen JAN, Sidhu P, Atallah B, El-Lababidi R, Al-Qahtani M. COVID-19: breaking down a global health crisis. Ann Clin Microbiol Antimicrob 2021;20:35. 10.1186/s12941-021-00438-7 PubMed DOI PMC
Shang Y, Li H, Zhang R. Effects of Pandemic Outbreak on Economies: Evidence From Business History Context. Front Public Health 2021;9:632043. 10.3389/fpubh.2021.632043 PubMed DOI PMC
Greffier J, Hoballah A, Sadate A, de Oliveira F, Claret PG, de Forges H, Loubet P, Mauboussin JM, Hamard A, Beregi JP, Frandon J. Ultra-low-dose chest CT performance for the detection of viral pneumonia patterns during the COVID-19 outbreak period: a monocentric experience. Quant Imaging Med Surg 2021;11:3190-9. 10.21037/qims-20-1176 PubMed DOI PMC
Sher L. Post-COVID syndrome and suicide risk. QJM 2021;114:95-8. 10.1093/qjmed/hcab007 PubMed DOI PMC
Liu JWTW, de Luca RD, Mello Neto HO, Barcellos I. Post-COVID-19 Syndrome? New daily persistent headache in the aftermath of COVID-19. Arq Neuropsiquiatr 2020;78:753-4. 10.1590/0004-282x20200187 PubMed DOI
Revzin MV, Raza S, Warshawsky R, D'Agostino C, Srivastava NC, Bader AS, Malhotra A, Patel RD, Chen K, Kyriakakos C, Pellerito JS. Multisystem Imaging Manifestations of COVID-19, Part 1: Viral Pathogenesis and Pulmonary and Vascular System Complications. Radiographics 2020;40:1574-99. 10.1148/rg.2020200149 PubMed DOI PMC
Revzin MV, Raza S, Srivastava NC, Warshawsky R, D'Agostino C, Malhotra A, Bader AS, Patel RD, Chen K, Kyriakakos C, Pellerito JS. Multisystem Imaging Manifestations of COVID-19, Part 2: From Cardiac Complications to Pediatric Manifestations. Radiographics 2020;40:1866-92. 10.1148/rg.2020200195 PubMed DOI PMC
Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, Lange F, Andersson JLR, Griffanti L, Duff E, Jbabdi S, Taschler B, Keating P, Winkler AM, Collins R, Matthews PM, Allen N, Miller KL, Nichols TE, Smith SM. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature 2022;604:697-707. 10.1038/s41586-022-04569-5 PubMed DOI PMC
Huang S, Zhou Z, Yang D, Zhao W, Zeng M, Xie X, Du Y, Jiang Y, Zhou X, Yang W, Guo H, Sun H, Liu P, Liu J, Luo H, Liu J. Persistent white matter changes in recovered COVID-19 patients at the 1-year follow-up. Brain 2022;145:1830-8. 10.1093/brain/awab435 PubMed DOI PMC
Klironomos S, Tzortzakakis A, Kits A, Öhberg C, Kollia E, Ahoromazdae A, Almqvist H, Aspelin Å, Martin H, Ouellette R, Al-Saadi J, Hasselberg M, Haghgou M, Pedersen M, Petersson S, Finnsson J, Lundberg J, Falk Delgado A, Granberg T. Nervous System Involvement in Coronavirus Disease 2019: Results from a Retrospective Consecutive Neuroimaging Cohort. Radiology 2020;297:E324-34. 10.1148/radiol.2020202791 PubMed DOI PMC
Díez-Cirarda M, Yus-Fuertes M, Sanchez-Sanchez R, Gonzalez-Rosa JJ, Gonzalez-Escamilla G, Gil-Martínez L, et al. Hippocampal subfield abnormalities and biomarkers of pathologic brain changes: from SARS-CoV-2 acute infection to post-COVID syndrome. EBioMedicine 2023;94:104711. 10.1016/j.ebiom.2023.104711 PubMed DOI PMC
Ajčević M, Iscra K, Furlanis G, Michelutti M, Miladinović A, Buoite Stella A, Ukmar M, Cova MA, Accardo A, Manganotti P. Cerebral hypoperfusion in post-COVID-19 cognitively impaired subjects revealed by arterial spin labeling MRI. Sci Rep 2023;13:5808. 10.1038/s41598-023-32275-3 PubMed DOI PMC
Mohammadi S, Ghaderi S. Post-COVID-19 conditions: a systematic review on advanced magnetic resonance neuroimaging findings. Neurol Sci 2024;45:1815-33. 10.1007/s10072-024-07427-6 PubMed DOI
Paolini M, Palladini M, Mazza MG, Colombo F, Vai B, Rovere-Querini P, Falini A, Poletti S, Benedetti F. Brain correlates of subjective cognitive complaints in COVID-19 survivors: A multimodal magnetic resonance imaging study. Eur Neuropsychopharmacol 2023;68:1-10. 10.1016/j.euroneuro.2022.12.002 PubMed DOI PMC
Clouston S, Huang C, Ying J, Sekendiz Z, Kritikos M, Fontana A, Bangiyev L, Luft B. Neuroinflammatory imaging markers in white matter: insights into the cerebral consequences of post-acute sequelae of COVID-19 (PASC). Res Sq [Preprint] 2024;rs.3.rs-3760289.
Díez-Cirarda M, Yus M, Gómez-Ruiz N, Polidura C, Gil-Martínez L, Delgado-Alonso C, Jorquera M, Gómez-Pinedo U, Matias-Guiu J, Arrazola J, Matias-Guiu JA. Multimodal neuroimaging in post-COVID syndrome and correlation with cognition. Brain 2023;146:2142-52. 10.1093/brain/awac384 PubMed DOI PMC
Molaverdi G, Kamal Z, Safavi M, Shafiee A, Mozhgani SH, Ghobadi MZ, Goudarzvand M. Neurological complications after COVID-19: A narrative review. eNeurologicalSci 2023;33:100485. 10.1016/j.ensci.2023.100485 PubMed DOI PMC
Fitsiori A, Nguyen D, Karentzos A, Delavelle J, Vargas MI. The corpus callosum: white matter or terra incognita. Br J Radiol 2011;84:5-18. 10.1259/bjr/21946513 PubMed DOI PMC
Filippi CG, Cauley KA. Lesions of the corpus callosum and other commissural fibers: diffusion tensor studies. Semin Ultrasound CT MR 2014;35:445-58. 10.1053/j.sult.2014.06.004 PubMed DOI
Planchuelo-Gómez Á, García-Azorín D, Guerrero ÁL, Rodríguez M, Aja-Fernández S, de Luis-García R. Structural brain changes in patients with persistent headache after COVID-19 resolution. J Neurol 2023;270:13-31. 10.1007/s00415-022-11398-z PubMed DOI PMC
Yeh FC, Verstynen TD, Wang Y, Fernández-Miranda JC, Tseng WY. Deterministic diffusion fiber tracking improved by quantitative anisotropy. PLoS One 2013;8:e80713. 10.1371/journal.pone.0080713 PubMed DOI PMC
Ardellier FD, Baloglu S, Sokolska M, Noblet V, Lersy F, Collange O, et al. Cerebral perfusion using ASL in patients with COVID-19 and neurological manifestations: A retrospective multicenter observational study. J Neuroradiol 2023;50:470-81. 10.1016/j.neurad.2023.01.005 PubMed DOI PMC
Sun C, Liu X, Bao C, Wei F, Gong Y, Li Y, Liu J. Advanced non-invasive MRI of neuroplasticity in ischemic stroke: Techniques and applications. Life Sci 2020;261:118365. 10.1016/j.lfs.2020.118365 PubMed DOI
Martinez-Heras E, Grussu F, Prados F, Solana E, Llufriu S. Diffusion-Weighted Imaging: Recent Advances and Applications. Semin Ultrasound CT MR 2021;42:490-506. 10.1053/j.sult.2021.07.006 PubMed DOI
Yeh FC, Wedeen VJ, Tseng WY. Generalized q-sampling imaging. IEEE Trans Med Imaging 2010;29:1626-35. 10.1109/TMI.2010.2045126 PubMed DOI
Fu Y, Pan Y, Li Z, Li Y. The Utility of Specific Antibodies Against SARS-CoV-2 in Laboratory Diagnosis. Front Microbiol 2020;11:603058. 10.3389/fmicb.2020.603058 PubMed DOI PMC
Jaganmohan D, Pan S, Kesavadas C, Thomas B. A pictorial review of brain arterial spin labelling artefacts and their potential remedies in clinical studies. Neuroradiol J 2021;34:154-68. 10.1177/1971400920977031 PubMed DOI PMC
Haller S, Haacke EM, Thurnher MM, Barkhof F. Susceptibility-weighted Imaging: Technical Essentials and Clinical Neurologic Applications. Radiology 2021;299:3-26. 10.1148/radiol.2021203071 PubMed DOI
Gwo CY, Zhu DC, Zhang R. Brain white matter hyperintensity lesion characterization in 3D T(2) fluid-attenuated inversion recovery magnetic resonance images: Shape, texture, and their correlations with potential growth. Front Neurosci 2022;16:1028929. 10.3389/fnins.2022.1028929 PubMed DOI PMC
Guest W, Krings T. Brain Arteriovenous Malformations: The Role of Imaging in Treatment Planning and Monitoring Response. Neuroimaging Clin N Am 2021;31:205-22. 10.1016/j.nic.2020.12.001 PubMed DOI
Mugler JP, 3rd, Brookeman JR. Three-dimensional magnetization-prepared rapid gradient-echo imaging (3D MP RAGE). Magn Reson Med 1990;15:152-7. 10.1002/mrm.1910150117 PubMed DOI
Andersson JL, Skare S, Ashburner J. How to correct susceptibility distortions in spin-echo echo-planar images: application to diffusion tensor imaging. Neuroimage 2003;20:870-88. 10.1016/S1053-8119(03)00336-7 PubMed DOI
Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, Bannister PR, De Luca M, Drobnjak I, Flitney DE, Niazy RK, Saunders J, Vickers J, Zhang Y, De Stefano N, Brady JM, Matthews PM. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004;23 Suppl 1:S208-19. 10.1016/j.neuroimage.2004.07.051 PubMed DOI
Yeh FC, Tseng WY. NTU-90: a high angular resolution brain atlas constructed by q-space diffeomorphic reconstruction. Neuroimage 2011;58:91-9. 10.1016/j.neuroimage.2011.06.021 PubMed DOI
Pinheiro J, Bates D, R Core Team. nlme: Linear and Nonlinear Mixed Effects Models 2023 R package version 3.1-163. Available online: https://cran.r-project.org/web/packages/nlme/nlme.pdf
Pinheiro JC, Bates DM. Mixed-Effects Models in S and S-PLUS. Springer, New York, 2000.
Box GEP, Cox DR. An Analysis of Transformations. Journal of the Royal Statistical Society 1964;26:211-52. 10.1111/j.2517-6161.1964.tb00553.x DOI
Holm S. A simple sequentially rejective multiple test procedure. Scandinavian Journal of Statistics 1979;6:5-70.
Alexander AL, Lee JE, Lazar M, Field AS. Diffusion tensor imaging of the brain. Neurotherapeutics 2007;4:316-29. 10.1016/j.nurt.2007.05.011 PubMed DOI PMC
Liang H, Ernst T, Oishi K, Ryan MC, Herskovits E, Cunningham E, Wilson E, Kottilil S, Chang L. Abnormal brain diffusivity in participants with persistent neuropsychiatric symptoms after COVID-19. NeuroImmune Pharm Ther 2023;2:37-48. 10.1515/nipt-2022-0016 PubMed DOI PMC
Greene C, Connolly R, Brennan D, Laffan A, O'Keeffe E, Zaporojan L, O'Callaghan J, Thomson B, Connolly E, Argue R, Meaney JFM, Martin-Loeches I, Long A, Cheallaigh CN, Conlon N, Doherty CP, Campbell M. Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment. Nat Neurosci 2024;27:421-32. 10.1038/s41593-024-01576-9 PubMed DOI PMC
Tanwar M, Singhal A, Alizadeh M, Sotoudeh H. Magnetic Resonance Imaging (MRI) Findings in COVID-19 Associated Encephalitis. Neurol Int 2023;15:55-68. 10.3390/neurolint15010005 PubMed DOI PMC
Kubo M, Kubo K, Kobayashi KI, Komiya N. Non-severe COVID-19 complicated by cytotoxic lesions of the corpus callosum (mild encephalitis/encephalopathy with a reversible splenial lesion): a case report and literature review. Int J Infect Dis 2022;125:1-9. 10.1016/j.ijid.2022.09.009 PubMed DOI PMC
Ohara H, Shimizu H, Kasamatsu T, Kajita A, Uno K, Lai KW, Vellingiri B, Sugie K, Kinoshita M. Cytotoxic lesions of the corpus callosum after COVID-19 vaccination. Neuroradiology 2022;64:2085-9. 10.1007/s00234-022-03010-y PubMed DOI PMC
Moors S, Nakhostin D, Ilchenko D, Kulcsar Z, Starkey J, Winklhofer S, Ineichen BV. Cytotoxic lesions of the corpus callosum: a systematic review. Eur Radiol 2023. [Epub ahead of print]. doi: .10.1007/s00330-023-10524-3 PubMed DOI PMC
Campabadal A, Oltra J, Junqué C, Guillen N, Botí MÁ, Sala-Llonch R, Monté-Rubio GC, Lledó G, Bargalló N, Rami L, Sánchez-Valle R, Segura B. Structural brain changes in post-acute COVID-19 patients with persistent olfactory dysfunction. Ann Clin Transl Neurol 2023;10:195-203. 10.1002/acn3.51710 PubMed DOI PMC
Teller N, Chad JA, Wong A, Gunraj H, Ji X, Goubran M, et al. Feasibility of diffusion-tensor and correlated diffusion imaging for studying white-matter microstructural abnormalities: Application in COVID-19. Hum Brain Mapp 2023;44:3998-4010. 10.1002/hbm.26322 PubMed DOI PMC
Shan D, Li S, Xu R, Nie G, Xie Y, Han J, Gao X, Zheng Y, Xu Z, Dai Z. Post-COVID-19 human memory impairment: A PRISMA-based systematic review of evidence from brain imaging studies. Front Aging Neurosci 2022;14:1077384. 10.3389/fnagi.2022.1077384 PubMed DOI PMC
Afsahi AM, Norbash AM, Syed SF, Sedaghat M, Afsahi G, Shahidi R, Tajabadi Z, Bagherzadeh-Fard M, Karami S, Yarahmadi P, Shirdel S, Asgarzadeh A, Baradaran M, Khalaj F, Sadeghsalehi H, Fotouhi M, Habibi MA, Jang H, Alavi A, Sedaghat S. Brain MRI findings in neurologically symptomatic COVID-19 patients: a systematic review and meta-analysis. J Neurol 2023;270:5131-54. 10.1007/s00415-023-11914-9 PubMed DOI
Bispo DDC, Brandão PRP, Pereira DA, Maluf FB, Dias BA, Paranhos HR, von Glehn F, de Oliveira ACP, Regattieri NAT, Silva LS, Yasuda CL, Soares AASM, Descoteaux M. Brain microstructural changes and fatigue after COVID-19. Front Neurol 2022;13:1029302. 10.3389/fneur.2022.1029302 PubMed DOI PMC
Jones DT, Graff-Radford J. Executive Dysfunction and the Prefrontal Cortex. Continuum (Minneap Minn) 2021;27:1586-601. 10.1212/CON.0000000000001009 PubMed DOI
García LF. Immune Response, Inflammation, and the Clinical Spectrum of COVID-19. Front Immunol 2020;11:1441. 10.3389/fimmu.2020.01441 PubMed DOI PMC
Shi Y, Wang Y, Shao C, Huang J, Gan J, Huang X, Bucci E, Piacentini M, Ippolito G, Melino G. COVID-19 infection: the perspectives on immune responses. Cell Death Differ 2020;27:1451-4. 10.1038/s41418-020-0530-3 PubMed DOI PMC
Pajuelo D, Dezortova M, Hajek M, Ibrahimova M, Ibrahim I. Metabolic changes assessed by 1H MR spectroscopy in the corpus callosum of post-COVID patients. MAGMA 2024. [Epub ahead of print]. doi: .10.1007/s10334-024-01171-w PubMed DOI PMC
Kansakar U, Trimarco V, Mone P, Varzideh F, Lombardi A, Santulli G. Choline supplements: An update. Front Endocrinol (Lausanne) 2023;14:1148166. 10.3389/fendo.2023.1148166 PubMed DOI PMC